Recent advances in inflammatory bowel disease therapeutics have led to impr
oved formulations of existing treatments and new indications for establishe
d drugs. Truly novel therapies based on recent understanding of pathogenesi
s are also being developed These new treatments and their likely impact on
the management of inflammatory bowel disease in the future are discussed.